Robin Van Bruggen

PI
Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands

Presentation(s):

• OC 44.3 - Exploring red blood cells as a novel tolerogenic approach for factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II

  Monday, June 26, 2023
  15:15 – 15:30 ET

• PB1398 - RBC-Derived Transglutaminase-2 Affects Thrombus Formation

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1440 - Lysis of In Vitro Whole Blood Clots Is Altered in Sickle Cell Disease

  Tuesday, June 27, 2023
  18:30 – 19:30 ET